These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study. Kim Y, Matsushita K, Sang Y, Grams ME, Skali H, Shah AM, Hoogeveen RC, Solomon SD, Ballantyne CM, Coresh J. Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023 [Abstract] [Full Text] [Related]
3. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements. Alehagen U, Dahlström U, Rehfeld JF, Goetze JP. Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063 [Abstract] [Full Text] [Related]
4. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study. Voroneanu L, Siriopol D, Nistor I, Apetrii M, Hogas S, Onofriescu M, Covic A. Kidney Blood Press Res; 2014 Nov; 39(6):636-47. PubMed ID: 25571877 [Abstract] [Full Text] [Related]
5. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study. Berge K, Lyngbakken MN, Myhre PL, Brynildsen J, Røysland R, Strand H, Christensen G, Høiseth AD, Omland T, Røsjø H. Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872 [Abstract] [Full Text] [Related]
6. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes. Costacou T, Saenger AK, Orchard TJ. Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616 [Abstract] [Full Text] [Related]
7. Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events. Gyanwali B, Lai MKP, Lui B, Liew OW, Venketasubramanian N, Richards AM, Chen C, Hilal S. Stroke; 2021 Jul; 52(7):2275-2283. PubMed ID: 33971742 [Abstract] [Full Text] [Related]
8. Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study). Puleo CW, Ayers CR, Garg S, Neeland IJ, Lewis AA, Pandey A, Drazner MH, de Lemos JA. Biomark Med; 2021 Nov; 15(16):1487-1498. PubMed ID: 34663078 [Abstract] [Full Text] [Related]
9. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study. Ishigami J, Hoogeveen RC, Ballantyne CM, Folsom AR, Coresh J, Selvin E, Matsushita K. Am J Epidemiol; 2019 Dec 31; 188(12):2146-2155. PubMed ID: 31063194 [Abstract] [Full Text] [Related]
10. Relationship between high-sensitivity cardiac troponin T and the prognosis of elderly inpatients with non-acute coronary syndromes. Wu W, Li DX, Wang Q, Xu Y, Cui YJ. Clin Interv Aging; 2018 Dec 31; 13():1091-1098. PubMed ID: 29922047 [Abstract] [Full Text] [Related]
11. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP. Kopec M, Duma A, Helwani MA, Brown J, Brown F, Gage BF, Gibson DW, Miller JP, Novak E, Jaffe AS, Apple FS, Scott MG, Nagele P. Anesth Analg; 2017 Feb 31; 124(2):398-405. PubMed ID: 28002165 [Abstract] [Full Text] [Related]
12. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A. Am Heart J; 2012 May 31; 163(5):821-8. PubMed ID: 22607860 [Abstract] [Full Text] [Related]
13. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population. Xu R, Ye P, Luo L, Sheng L, Wu H, Xiao W, Zheng J, Wang F, Xiao T. Chin Med J (Engl); 2014 May 31; 127(4):638-44. PubMed ID: 24534215 [Abstract] [Full Text] [Related]
14. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina. Caselli C, Prontera C, Liga R, De Graaf MA, Gaemperli O, Lorenzoni V, Ragusa R, Marinelli M, Del Ry S, Rovai D, Giannessi D, Aguade-Bruix S, Clemente A, Bax JJ, Lombardi M, Sicari R, Zamorano J, Scholte AJ, Kaufmann PA, Knuuti J, Underwood SR, Clerico A, Neglia D. Arterioscler Thromb Vasc Biol; 2016 Apr 31; 36(4):757-64. PubMed ID: 26868212 [Abstract] [Full Text] [Related]
15. Premorbid levels of high-sensitivity cardiac troponin T and natriuretic peptide and prognosis after incident myocardial infarction. Mok Y, Sang Y, Ballew SH, Hoogeveen RC, Ballantyne CM, Rosamond W, Coresh J, Selvin E, Matsushita K. Am Heart J; 2019 Oct 31; 216():62-73. PubMed ID: 31404723 [Abstract] [Full Text] [Related]
16. Repeated Measurements of Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Assess Long-Term Mortality Risk in Subjects with Osteoarthritis. Rehm M, Büchele G, Brenner RE, Günther KP, Brenner H, Koenig W, Rothenbacher D. Biomolecules; 2021 Feb 05; 11(2):. PubMed ID: 33562838 [Abstract] [Full Text] [Related]
17. Unstable coronary plaque characteristics are associated with high-sensitivity cardiac troponin T and N-terminal Pro-Brain Natriuretic Peptide. Altintas S, Cardinaels EP, Versteylen MO, Joosen IA, Seifert M, Wildberger JE, Crijns HJ, Nelemans PJ, Van Dieijen-Visser MP, Mingels AM, Das M, Kietselaer BL. J Cardiovasc Comput Tomogr; 2016 Feb 05; 10(1):82-8. PubMed ID: 26481512 [Abstract] [Full Text] [Related]
18. Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study. Dallmeier D, Denkinger M, Peter R, Rapp K, Jaffe AS, Koenig W, Rothenbacher D, ActiFE Study Group. Clin Chem; 2015 Feb 05; 61(2):389-99. PubMed ID: 25501933 [Abstract] [Full Text] [Related]
19. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Apple FS, Murakami MM, Pearce LA, Herzog CA. Clin Chem; 2004 Dec 05; 50(12):2279-85. PubMed ID: 15364888 [Abstract] [Full Text] [Related]
20. Cardiac biomarkers are associated with increased risks of adverse clinical outcomes after ischemic stroke. Chang X, Xia S, Liu Y, Mao X, Wu X, Chu M, Niu H, Sun L, He Y, Liu Y, Guo D, Shi M, Zhang Y, Zhu Z, Zhao J. J Neurol; 2024 Sep 05; 271(9):6313-6324. PubMed ID: 39105893 [Abstract] [Full Text] [Related] Page: [Next] [New Search]